Market Place
Sourcing Support
All News #Library
Others
Upstream Bio To Join March Investor Conference
25 Feb 2026 //
GLOBENEWSWIRE
Upstream Bio To Present At 44Th J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
Upstream Bio To Join December Investor Conferences
25 Nov 2025 //
GLOBENEWSWIRE
Upstream Bio Reports Q2 2025 Financial Results, Highlights
06 Aug 2025 //
GLOBENEWSWIRE
Upstream Bio Begins Phase 2 Trial of Verekitug for COPD
08 Jul 2025 //
GLOBENEWSWIRE
Upstream Bio Appoints Stacy Price as Chief Technology Officer
20 May 2025 //
GLOBENEWSWIRE
Upstream Bio Reports Q1 2025 Results, Speeds Clinical Programs
06 May 2025 //
GLOBENEWSWIRE
Upstream Bio Reports Q4, 2024 Financials, Highlights Recent Business
12 Mar 2025 //
GLOBENEWSWIRE
Upstream Bio to Present at Upcoming March Investor Conferences
25 Feb 2025 //
GLOBENEWSWIRE
Upstream Bio to Present at the 43rd Annual J.P. Morgan Conference
06 Jan 2025 //
GLOBENEWSWIRE
Upstream Bio to Attend Piper Sandler 36th Annual Healthcare Conf.
21 Nov 2024 //
GLOBENEWSWIRE
Upstream Bio Q3 2024 Results & Recent Business Highlights
07 Nov 2024 //
GLOBENEWSWIRE
Upstream swells IPO to $255M as it lists alongside CAMP4
11 Oct 2024 //
FIERCE BIOTECH
Upstream Bio Announces Oral Presentation Of New Data
09 Sep 2024 //
GLOBENEWSWIRE
Upstream Bio To Present Verekitug Asthma Dose Ranging Results At ATS Conference
15 May 2024 //
GLOBENEWSWIRE
Upstream Bio Announces Appointment of Rand Sutherland as CEO
02 Apr 2024 //
BUSINESSWIRE
Upstream Bio Announces Positive Phase 1b Interim Data in Asthma
24 Oct 2023 //
BUSINESSWIRE
Upstream matches first funding round with $200M to get asthma drug to PhIII
08 Jun 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.